Hypercholesterolemia
What's New
Last Posted: Jun 27, 2024
- Application of implementation science for improving the utilization of an international clinical practice guidance on familial hypercholesterolemia.
Laney K Jones et al. J Clin Lipidol 2024 - Familial hypercholesterolemia care by Dutch pediatricians-mind the gaps.
Sibbeliene E van den Bosch et al. Eur J Pediatr 2024 - The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis.
Ryan Lokkesmoe et al. Curr Atheroscler Rep 2024 - Improving the Detection of Potential Cases of Familial Hypercholesterolemia: Could Machine Learning Be Part of the Solution?
- Influence of Polygenic Background on the Clinical Presentation of Familial Hypercholesterolemia.
Mark Trinder et al. Arterioscler Thromb Vasc Biol 2024 - Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
M Doortje Reijman et al. Lancet Child Adolesc Health 2024 - Design and Pilot Results from Million Veteran Program Return Of Actionable Genetic Results (MVP-ROAR) Study.
Jason L Vassy et al. Am Heart J 2024 - Algorithm for detection and screening of familial hypercholesterolemia in Lithuanian population.
Urte Aliosaitiene et al. Lipids Health Dis 2024 23(1) 136 - Evinacumab and Cardiovascular Outcome in Patients With Homozygous Familial Hypercholesterolemia.
Sophie Béliard et al. Arterioscler Thromb Vasc Biol 2024 - It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States.
Samuel S Gidding et al. Glob Heart 2024 19(1) 43 - An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.
Lauren E Hendy et al. Atherosclerosis 2024 393117541 - Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
Shirin Ibrahim et al. Atherosclerosis 2024 393117548 - Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial
- The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?
Lauren Gima et al. Clin Colon Rectal Surg 2024 37(3) 133-139 - A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.
Marlys L Koschinsky et al. J Clin Lipidol 2024 - The Health History of First-Degree Relatives' Dyslipidemia Can Affect Preferences and Intentions following the Return of Genomic Results for Monogenic Familial Hypercholesterolemia.
Tomoharu Tokutomi et al. Genes (Basel) 2024 15(3) - Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry.
Loukianos S Rallidis et al. J Cardiovasc Med (Hagerstown) 2024 - Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United States.
Vivienne Souter et al. Circ Genom Precis Med 2024 3 e004457 - Efficacy of Inclisiran in patients having familial hypercholesterolemia: heterozygous compared to homozygous trait, a systematic review and meta analysis.
Rahul Rai et al. Crit Pathw Cardiol 2024 - Exploring the Landscape of Familial Hypercholesterolemia: Unraveling Genetic Complexity and Clinical Implications.
Fotios Barkas et al. Eur J Intern Med 2024
More
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: